The Fenway Institute at Boston-based Fenway Health—one of the nation’s foremost health centers for care and research focused on LGBTQIA+ health and HIV/AIDS—is launching a new study into how our bodies respond to and recover from COVID-19.
“As part of the global response to the AIDS pandemic, The Fenway Institute built up the capacity to conduct cutting edge clinical research as part of the NIH’s HIV Vaccine and HIV Prevention Trials Networks (HVTN and HPTN),” Dr. Kenneth Mayer, Fenway’s medical research director and Fenway Institute co-director, said in a press release announcing the study.
“This infrastructure is now being repurposed to address the COVID-19 pandemic,” Mayer said. “This study will help inform the development of vaccine trials, which will also be conducted at The Fenway Institute.”
According to the release:
Eligible study participants include anyone 18 years or older who has tested positive for COVID-19. …
Study participants will be asked to take part in at least one study visit, with the potential of three additional visits over the course of on year. Participants will be compensated for their time and contributions to this potentially life-saving research.
Your immune system could help researchers end the global pandemic. Please consider joining this study and join the battle against COVID-19.
Ready to sign up? Please click here to take an online screener to see if you may be eligible.
To learn more about this study, please call us at 617.927.6450, email us at bethechange@fenwayhealth.org, or text @COVID to 39242.
Not a subscriber? Sign up today for a free subscription to Boston Spirit magazine, New England’s premier LGBT magazine. We will send you a copy of Boston Spirit 6 times per year and we never sell/rent our subscriber information. Click HERE to sign up!
